Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients

By Ustuner Zeki   Saip Pinar   Yasasever Vildan   Vural Burcak   Yazar Aziz   Bal Cengiz   Ozturk Betul   Ozbek Ugur   Topuz Erkan  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 394-399

Humana Press, Inc

Access to resources Recommend Favorite

Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer

By                                

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1297-1304

Spandidos Publications

Access to resources Recommend Favorite

Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer

By Yonemura Y.   Fushida S.   Bando E.   Kinoshita K.   Miwa K.   Endo Y.   Sugiyama K.   Partanen T.   Yamamoto H.   Sasaki T.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 918-923

Elsevier

Access to resources Recommend Favorite

Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma

By Groves Morris   Hess Kenneth   Puduvalli Vinay   Colman Howard   Conrad Charles   Gilbert Mark   Weinberg Jeffrey   Cristofanilli Massimo   Yung W.   Liu Ta-Jen  

Journal of Neuro-Oncology, Vol. 94, Iss. 2, 2009-09 ,pp. : 229-234

Springer Publishing Company

Access to resources Recommend Favorite

Suppression of lung cancer cell invasion by LKB1 is due to the downregulation of tissue factor and vascular endothelial growth factor, partly dependent on SP1

By Liang Xuan   Li Zhao-Lun   Jiang Li-Li   Guo Qian-Qian   Liu Meng-Jie   Nan Ke-Jun  

International Journal of Oncology, Vol. 44, Iss. 6, 2014-06 ,pp. : 1989-1997

Spandidos Publications

Access to resources Recommend Favorite